296 related articles for article (PubMed ID: 20519630)
41. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
42. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
[TBL] [Abstract][Full Text] [Related]
43. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
[TBL] [Abstract][Full Text] [Related]
44. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
45. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Ravi D; Beheshti A; Abermil N; Passero F; Sharma J; Coyle M; Kritharis A; Kandela I; Hlatky L; Sitkovsky MV; Mazar A; Gartenhaus RB; Evens AM
Cancer Res; 2016 Jun; 76(11):3319-31. PubMed ID: 26988986
[TBL] [Abstract][Full Text] [Related]
46. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
47. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
48. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
49. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
50. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
51. High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.
Shams TM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):147-53. PubMed ID: 22776842
[TBL] [Abstract][Full Text] [Related]
52. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
[TBL] [Abstract][Full Text] [Related]
53. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
54. Expression of Myc target gene mina53 in subtypes of human lymphoma.
Teye K; Arima N; Nakamura Y; Sakamoto K; Sueoka E; Kimura H; Tsuneoka M
Oncol Rep; 2007 Oct; 18(4):841-8. PubMed ID: 17786344
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
56. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
Jardin F; Buchonnet G; Parmentier F; Contentin N; Leprêtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
[TBL] [Abstract][Full Text] [Related]
57. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.
Leventaki V; Drakos E; Karanikou M; Psatha K; Lin P; Schlette E; Eliopoulos A; Vassilakopoulos TP; Papadaki H; Patsouris E; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2014 Mar; 45(3):565-72. PubMed ID: 24457077
[TBL] [Abstract][Full Text] [Related]
58. Patterns of microRNA expression characterize stages of human B-cell differentiation.
Zhang J; Jima DD; Jacobs C; Fischer R; Gottwein E; Huang G; Lugar PL; Lagoo AS; Rizzieri DA; Friedman DR; Weinberg JB; Lipsky PE; Dave SS
Blood; 2009 May; 113(19):4586-94. PubMed ID: 19202128
[TBL] [Abstract][Full Text] [Related]
59. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
[TBL] [Abstract][Full Text] [Related]
60. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
